Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $703,136 - $791,896
5,110 New
5,110 $791,000
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $5.17 Million - $5.93 Million
38,508 New
38,508 $5.17 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $7.06 Million - $8.01 Million
-66,349 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $6.98 Million - $7.78 Million
66,349 New
66,349 $7.47 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Weiss Asset Management LP Portfolio

Follow Weiss Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Asset Management LP with notifications on news.